Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2025-12-26 @ 3:05 AM
Study NCT ID:
NCT01222520
Status:
COMPLETED
Last Update Posted:
2014-06-27
First Post:
2010-10-15
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Telmisartan 80mg Non-responder Trial
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-10
Start Date Type:
None
Primary Completion Date:
2011-06
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2010-10-15
First Submit QC Date:
None
Study First Post Date:
2010-10-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-05-31
Results First Submit QC Date:
None
Results First Post Date:
2012-07-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-06-17
Last Update Post Date:
2014-06-27
Last Update Post Date Type:
ESTIMATED